Harvard University

Activities: Training & Education Research & Development

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  4. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  5. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Research & Development

New Harvard consortium focuses on advanced bioproduction

The overarching mission of the collaboration is to catalyse the development of transformative therapies by shortening the path between research and clinical application
Research & Development

Malaysian scientists join Harvard team to create effective nano drugs

Will assess how nanomedicine particles behave in the body, what attaches to them to form a coating, where the drug accumulates and how it interacts with target and non-target cells
Drug Delivery

Drug-device combination opens potential path to treat stroke

Obstructed blood clots in the brain could be cleared using a device that opens a small channel through the blockage in combination with a clot-busting drug
Regulatory

Wyss Institute introduces new biosafety assessment process

The pre-emptive biosafety model looks to cover potential biosafety risks from new biotechnologies
Research & Development

Patient stem cells used to make ‘heart disease-on-a-chip’ as testing platform for drugs

Research could signify a big step forward for personalised medicine
Subscribe now